APPLIED GENOMICS INC has a total of 19 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are AURELIUM BIOPHARMA INC, OPEXA THERAPEUTICS INC and NeuroDiagnostics LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 4 | |
#3 | Canada | 2 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Seitz Robert S | 16 |
#2 | Ring Brian Z | 16 |
#3 | Ross Douglas T | 16 |
#4 | Beck Rodney A | 6 |
#5 | Ross Douglas | 3 |
#6 | Brown Patrick O | 3 |
#7 | Ring Brian | 3 |
#8 | Seitz Rob | 3 |
#9 | Botstein David | 3 |
#10 | Perou Chuck | 3 |
Publication | Filing date | Title |
---|---|---|
WO2009073478A2 | Tle3 as a marker for chemotherapy | |
WO2009117004A1 | Reagents and methods for use in head and neck cancer diagnosis, classification and therapy | |
WO2008043104A2 | Reagents and methods for use in cancer diagnosis, classification and therapy | |
US2007065888A1 | Reagents and methods for use in cancer diagnosis, classification and therapy | |
WO2006132683A2 | Reagents and methods for use in cancer diagnosis, classification and therapy | |
WO2005085863A2 | Biomarker: compound correlations in cancer diagnosis and therapy | |
WO2005017530A1 | Reagents and methods for use in cancer diagnosis, classification and therapy |